Reporte zur Charge BV GJ3277

Symptomtext

Triggered onset of rheumatoid arthritis.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 24-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Oct2022 as dose 4 (booster), single (Lot number: GJ3277) at the age of 24 years, in right arm for covid-19 immunisation; influenza vaccine inact split 3v (FLUARIX), on 17Oct2022 as dose 1, single (Batch/Lot number: unknown), in left arm for influenza immunisation. The patient's relevant medical history included: "PCOS" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTATIN CALCIUM; ESCITALOPRAM OXALATE; YAZ. Vaccination history included: BNT162b2 (Dose 3 (booster), Single, Batch/Lot No: FF2590, Anatomical Location: Arm Right), administration date: 19Nov2021, for COVID-19 immunization; BNT162b2 (Dose 2, Single, Batch/Lot No: EW0151, Anatomical Location: Arm Right), administration date: 01May2021, for COVID-19 immunization; BNT162b2 (Dose 1, Single, Batch/Lot No: ER8729, Anatomical Location: Arm Right), administration date: 09Apr2021, for COVID-19 immunization. The following information was reported: RHEUMATOID ARTHRITIS (medically significant) with onset 17Oct2022, outcome "not recovered", described as "Triggered onset of rheumatoid arthritis.". The event "triggered onset of rheumatoid arthritis." required physician office visit. Therapeutic measures were taken as a result of rheumatoid arthritis. Clinical Course: Extreme joint pain with increased rheumatoid factors. Triggered onset of rheumatoid arthritis. Treatment Included: NSAIDs, Levothyroxine. Patient was not tested positive for COVID-19 post vaccination or had COVID-19 prior vaccination.